Consumption of fish oil by patients suffering from diabetes and cardiovascular diseases has sparked discussion across medical circles. Type 2 diabetes is currently being studied across world-renowned medical research institutes. A recent study conducted at the University of Anglia reveals key information about type 2 diabetes. The research study found that omega-3 fats have no role in triggering type 2 diabetes. This is an eye-opener for individuals consuming fish oil to reverse the impact of diabetes.
Diabetics are the largest consumers of omega-3 fats believing that it controls blood sugar levels. However, the new research busts this fallacy through in-depth studies and experiments. The research was vetted by the World Health Organization (WHO), and the findings are published in British Medical Journal. The research clearly states that omega-3 supplements such as fish oil are futile in treatment of diabetes.
Busting Myths about Omega-3 Fats
The researchers tested fish oil consumption patterns on a random sample of 58,000 participants. From this sample, 4% people developed diabetes during the course of the experiment. Further, people consuming relatively larger quantities of fish oil had the same risk of developing diabetes as others. Furthermore, insulin, glucose, and hemoglobin levels are important indicators of diabetes in humans. Omega-3 fats, or fish oils, has no effect on any of these indicators either. This further strengthened the premise of this research for scientists.
Farfetched Evidence to Support Current Beliefs
The researchers found virtual independence of omega-3 consumption and diabetes diagnosis. However, there was weak evidence to support that increased consumption of fish oils slowed-down glucose metabolism. Consumption of controlled amount of fish oil can be good for health. Omega-3 fats are also found in several foods consumed by humans. Eicosapentaenoic acid (EPA), alpha¬linolenic acid (ALA), and docosahexaenoic acid (DHA) are the most common types of omega-3 fats. The research study has opened new avenues for research across the field of diabetes diagnosis.